Crispr Therapeutics shares owned by Affinity Asset Advisors
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Affinity Asset Advisors
from 13F filings
Historical chart of Affinity Asset Advisors investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Affinity Asset Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $4.4M | 65k | 68.16 |
| 2022-06-30 | $4.3M | 70k | 60.77 |
| 2022-03-31 | $3.5M | 55k | 62.76 |
| 2020-12-31 | $536k | 3.5k | 153.14 |